missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18769788

Human ROR1 Alexa Fluor™ 405-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  R&D Systems FAB20001V-100UG

Product Code. 18769788

  • € 500.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ROR1 Monoclonal specifically detects ROR1 in Human samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ROR1
Monoclonal
Alexa Fluor 405
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
EC 2.7.10.1, MGC99659, neurotrophic tyrosine kinase receptor-related 1, Neurotrophic tyrosine kinase, receptor-related 1, NTRKR1, NTRKR1dJ537F10.1, receptor tyrosine kinase-like orphan receptor 1, tyrosine-protein kinase transmembrane receptor ROR1
Chinese hamster ovary cell line CHO-derived recombinant human ROR1, Ala24-Glu403, Accession # Q01973
100 μg
4919
Human
Supernatant
Flow Cytometry
1011919
Flow Cytometry 0.25-1 μg/106 cells
Q01973
Mouse
Protein A or G purified from hybridoma culture supernatant
Primary
Detects human ROR1 in direct ELISAs.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8°C as supplied.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.